{"classes":[{"categories":[{"measurements":[{"comment":"Not calculable/estimable due to low number of participants with events","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"420.0"},{"comment":"Not calculable/estimable due to low number of participants with events","groupId":"OG001","lowerLimit":"57.0","upperLimit":"NA","value":"NA"},{"comment":"Not calculable/estimable due to low number of participants with events","groupId":"OG002","lowerLimit":"57.0","upperLimit":"NA","value":"420.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"8"}],"units":"Participants"}],"description":"TTP for a given participant is defined as the number of days from the date of first dose to the date of first documented disease progression (PD) or death due to multiple myeloma (MM), whichever occurs first. If the participant did not have an event of PD and the participant had not died due to MM, the participant's data was to be censored.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants positive for t(11;14) translocation who received at least 1 dose of study drug (venetoclax 400 mg, pomalidomide 4 mg, and dexamethasone 40 mg)","id":"OG000","title":"Participants Positive for t(11;14) Translocation"},{"description":"Participants negative for t(11;14) translocation who received at least 1 dose of study drug (venetoclax 400 mg, pomalidomide 4 mg, and dexamethasone 40 mg)","id":"OG001","title":"Participants Negative for t(11;14) Translocation"},{"description":"Participants who received at least 1 dose of study drug (venetoclax 400 mg, pomalidomide 4 mg, and dexamethasone 40 mg)","id":"OG002","title":"All Participants"}],"paramType":"MEDIAN","populationDescription":"Full Analysis Set: participants who received at least 1 dose of study drug (venetoclax 400 mg, pomalidomide 4 mg, and dexamethasone 40 mg) and had disease progression or death due to multiple myeloma","reportingStatus":"POSTED","timeFrame":"Approximately 15 months","title":"Time-to-progression (TTP)","type":"SECONDARY","unitOfMeasure":"days"}